Caris Life Sciences has secured a significant financing agreement, collaborating with lenders from Blue Owl Capital and Blackstone. The new credit facilities include a $400 million term loan, a potential $300 million delayed draw term loan for acquisitions, and an uncommitted $500 million facility. The term loan matures in April 2031, with interest rates set at an additional 4.00% to 5.00% depending on the rate type. The agreement includes various covenants and security agreements, requiring the company to maintain minimum cash reserves and allowing lenders to act in case of defaults.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.abfjournal.com/caris-life-sciences-secures-up-to-1-2b-senior-secured-facilities-from-blue-owl-blackstone/
